| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/08/2006 | EP1631281A2 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 03/08/2006 | EP1631279A2 Combination therapy for the treatment of neoplasms |
| 03/08/2006 | EP1631278A1 Combination chemotherapy comprising capecitabine and a liposomal platinum complex |
| 03/08/2006 | EP1631276A2 Compositions for the enhanced treatment of depression |
| 03/08/2006 | EP1631274A2 Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders |
| 03/08/2006 | EP1631268A2 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 03/08/2006 | EP1631267A2 Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites |
| 03/08/2006 | EP1631266A2 A method of treating degenerative disc disease |
| 03/08/2006 | EP1631258A1 Combination chemotherapy comprising gemcitabine and a liposomal platinum complex |
| 03/08/2006 | EP1631255A2 Drug delivery system |
| 03/08/2006 | EP1631146A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1465627B1 DOSING REGIMEN FOR PPAR−GAMMA ACTIVATORS |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1448592B1 Steroidal compounds for inhibiting steroid sulphatase |
| 03/08/2006 | EP1429689A4 Rational drug therapy device and methods |
| 03/08/2006 | EP1365761B1 Therapeutic combination of amlodipine and benazepril |
| 03/08/2006 | EP1347753B1 Topical composition and method for treating urinary stress incontinence |
| 03/08/2006 | EP1346221B1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 03/08/2006 | EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1276503B1 Screening methods for inhibitors of an acrab and an acrab-like efflux pump |
| 03/08/2006 | EP1263422B1 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd) |
| 03/08/2006 | EP1244670B1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 03/08/2006 | EP1223913B1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 03/08/2006 | EP1220611B1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 03/08/2006 | EP1206261B1 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 03/08/2006 | EP1079806B1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |
| 03/08/2006 | EP1041995B1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 03/08/2006 | EP0889727B1 Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
| 03/08/2006 | EP0800532B1 Improved cyclic crf agonists |
| 03/08/2006 | CN1745074A 5-HT receptor ligands and uses thereof |
| 03/08/2006 | CN1744919A Method and composition for treating tumors by selective induction of apoptosis |
| 03/08/2006 | CN1744917A Sustained-release pharmaceutical composition for lung administration |
| 03/08/2006 | CN1744916A Preventive or remedy for diseases caused by hyperglycemia |
| 03/08/2006 | CN1744910A Drugs containing galectin 9 |
| 03/08/2006 | CN1744905A Topical anti-infective formulations |
| 03/08/2006 | CN1744901A Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis |
| 03/08/2006 | CN1744897A Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 03/08/2006 | CN1744884A Solid preparation for dialysis and process for producing the same |
| 03/08/2006 | CN1744874A Composition for preventive treatment of herpessimplex |
| 03/08/2006 | CN1744822A Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
| 03/08/2006 | CN1743007A Inflammation-resistant modified imvite and preparing method thereof |
| 03/08/2006 | CN1743006A New use of MAPK inhibitor and its composition thereof |
| 03/08/2006 | CN1743005A New use of PI3-K inhibitor and its composition |
| 03/08/2006 | CN1743004A Compound preparation for anti-pregnancy by killing sperm and sterilizing, preparation method thereof |
| 03/08/2006 | CN1743003A Compound preparation for anti-pregnancy by kiilling sperm and sterilizing and preparing method |
| 03/08/2006 | CN1742731A Pyrazole-di-pyridineones for treating female sexual dysfunction |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/08/2006 | CN1244327C Thebaic analgesic with controllable release of active content |
| 03/08/2006 | CN1244322C Use of inhibitors of sodium-hydrogen exchanging pump for production of medicine for treatment of disorders which are caused by protozoa |
| 03/08/2006 | CN1244281C Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 03/07/2006 | US7008956 p53 inhibitors and therapeutic use of the same |
| 03/07/2006 | US7008947 Use to treat anxiety, depression, a sleep disorder such as primary insomnia, circadian rhythm sleep disorder, dyssomnia NOS, nightmare disorder, or attention deficit disorder |
| 03/07/2006 | US7008936 Such as (1S-1R*,3R*(E),7R*,10S*,11R*,12R*,16S*))-7,11-dihydroxy-8,8,10,12,16 -pentamethyl-3-(1-methyl-2-(2-methy l-4-thiazolyl)ethenyl)-4-aza-17-oxabicyclo(14.1.0)heptadecane-5,9-dione combined with carboplatin |
| 03/07/2006 | US7008920 comprising pharmacologically active substance, drug absorbefacient and taurine compound or polyamine; suppressing or preventing damage of the intestinal mucous membrane |
| 03/07/2006 | US7008773 Method for identifying active anti apoptosis compounds |
| 03/07/2006 | US7008661 Oil/fat composition |
| 03/07/2006 | US7008649 administering compositions of eugenol and forskolin; for treating and/or preventing soft tissue cancer in mammals |
| 03/07/2006 | US7008646 Comprising encapsulating compound, amphiphile capable of forming a cubic liquid crystalline phase, and optionally a solvent; powders that form cubic liquid crystalline particles on hydration |
| 03/07/2006 | US7008645 Bisphosphonate compound |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/07/2006 | US7008627 dermocosmetic blends useful for improving and treating hyperreactive skin conditions, allergic-type reactions and/or intolerance; anti-radical, anti-inflammatory and anti-allergenic; immunomodulatory activity |
| 03/07/2006 | US7008616 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 03/07/2006 | US7008615 Delivery of anti-migraine compounds through an inhalation route |
| 03/07/2006 | US7008444 Method of controlling body temperature while reducing shivering |
| 03/07/2006 | CA2332983C Sitostanol formulation with emulsifier to reduce cholesterol absorption |
| 03/07/2006 | CA2265795C Therapeutic agent with quantitative consumption marker and method of monitoring therapeutic agent consumption |
| 03/02/2006 | WO2006023714A2 Dithiocarbamate derivatives and their use for treating cancer |
| 03/02/2006 | WO2006022428A1 Remedy for diabetes |
| 03/02/2006 | WO2006022420A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 03/02/2006 | WO2006022344A1 Utilization of anti-mortalin 2 antibody and functional nucleic acid in treating cancer |
| 03/02/2006 | WO2006022340A1 Composite fine particles and process for producing the same |
| 03/02/2006 | WO2006022281A1 Preventive and remedy for collagen or elastin metabolic disorder |
| 03/02/2006 | WO2006021443A2 Composition comprising an at1 receptor blocker and a macrolide t-cell immunomodulator |
| 03/02/2006 | WO2006021412A2 Use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| 03/02/2006 | WO2006006933A3 Antiproliferative compositions comprising aryl substituted xylopyranoside derivatives |
| 03/02/2006 | WO2005123193A3 Treatments comprising strontium for rheumatic and arthritic diseases and pain |
| 03/02/2006 | WO2005117979A3 Use of il-17 in the treatment of fertility-related disorders |
| 03/02/2006 | WO2005107717A8 Oral dosage form for the extended release of biguanide and sulfonylurea |
| 03/02/2006 | WO2005105133A3 Methods and compositions for preserving the viability of photoreceptor cells |
| 03/02/2006 | WO2005101838A3 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 03/02/2006 | WO2005084462A3 Nanoscale and supersaturated solutions of mineral or trace elements and a method for production of nanoparticles mixtures of nanoparticles, nanoscale solutions and general supersaturated solutions |
| 03/02/2006 | WO2005079774A3 Management of ophthalmologic disorders, including macular degeneration |
| 03/02/2006 | WO2005051331A3 Chaperone-based therapy for niemann-pick disease |
| 03/02/2006 | WO2004046331A3 2’-branched nucleosides and flaviviridae mutation |
| 03/02/2006 | WO2004032869A3 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
| 03/02/2006 | WO2003090686A3 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 03/02/2006 | WO2003082208A3 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 03/02/2006 | US20060046979 Organic compounds |
| 03/02/2006 | US20060045853 Using tissue plasminogen activator finger domain specific immunolglobulins as tool in diagnosis of diabbetes and/or alzheimer's disease |
| 03/02/2006 | DE202005019214U1 Use of local pharmaceutical formulation comprising 5-serotonin-receptor-antagonist for the treatment of e.g. skin infections e.g. burns, radiation damage of the skin and other exogenous skin damage, psoriasis and neurodermatitis |
| 03/02/2006 | DE102005035472A1 Chemische Dialysatformulierungen auf Citratbasis Dry on citrate dialysate |
| 03/02/2006 | DE102004041270A1 Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung A capillary containing active system compositions with application-specific differentiation and their use |
| 03/02/2006 | DE102004039196A1 Neue Formulierung für L-Tryptophan New formulation of L-tryptophan |
| 03/02/2006 | CA2577777A1 Methods of healing wounds by administering human il-18 |
| 03/02/2006 | CA2573125A1 Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| 03/01/2006 | EP1629849A2 Pharmaceutical compositions comprising exendins and agonists thereof |